患者经历「临床前期类风湿关节炎」各阶段时感染风险的时间变化:苏格兰早期类风湿关节炎起始队列结果
苏格兰早期类风湿关节炎起始队列研究分析了新诊断类风湿关节炎患者在「临床前期类风湿关节炎」各阶段及早期关节炎期的社区与医院感染发生率,并与年龄和性别匹配的对照比较。结果显示症状出现前0-6个月抗生素处方发生率比即升高(IRR 1.28,95%CI 1.15-1.42),症状性临床前期类风湿关节炎期IRR为1.33(95%CI 1.18-1.49)并持续至早期关节炎期;住院率在临床前期类风湿关节炎期数值上更高,在早期关节炎期显著更高(IRR 1.82,95%CI 1.32-2.46)。
要点
- 症状出现前至少6个月抗生素处方风险已升高,IRR 1.28(95%CI 1.15-1.42)。
- 症状性临床前期类风湿关节炎期IRR 1.33(95%CI 1.18-1.49),持续至早期关节炎期。
- 早期关节炎期住院率显著升高,IRR 1.82(95%CI 1.32-2.46)。
核心结论
- 临床前期类风湿关节炎患者在症状出现前至少6个月抗生素风险已升高,并持续贯穿症状性临床前期类风湿关节炎阶段。
- 感染可能在驱动类风湿关节炎进展的机制中起作用,或为免疫功能障碍的表现,或两者兼有。
- 这些观察可为临床前期类风湿关节炎干预措施的安全性和有效性考量提供信息。
- 反复使用抗生素的临床前期类风湿关节炎患者可能是一个可识别的高风险群体,可富集临床前期类风湿关节炎干预研究的研究人群。
研究设计与样本
- 苏格兰早期类风湿关节炎起始队列研究,招募新诊断类风湿关节炎患者。
- 通过社区抗生素处方确定感染发生率,通过出院编码确定严重感染。
- 利用诊断日期和症状出现日期识别无症状临床前期类风湿关节炎、症状性临床前期类风湿关节炎和早期关节炎期,分析感染率随时间变化,并与年龄和性别匹配的对照比较。
主要发现
- 症状出现前0-6个月期间的发生率比IRR为1.28(95%CI 1.15-1.42)。
- 症状性临床前期类风湿关节炎期IRR为1.33(95%CI 1.18-1.49),并持续至早期关节炎期。
- 住院率在临床前期类风湿关节炎期数值上更高,在早期关节炎期显著更高(IRR 1.82,95%CI 1.32-2.46)。
临床怎么用
- 作者认为这些观察可为临床前期类风湿关节炎干预措施的安全性和有效性考量提供信息。
- 作者认为反复使用抗生素的临床前期类风湿关节炎患者可能是一个可识别的高风险群体,可富集临床前期类风湿关节炎干预研究的研究人群。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: ObjectiveRheumatoid arthritis (RA) develops after progressing through sequential 'pre-RA' phases. The mechanisms driving progression from one phase to the next remain poorly understood. This study examined the longitudinal rates of community and hospital infections in patients during sequential stages of pre-RA and early arthritis. METHODS: The Scottish Early RA inception cohort recruited patients with newly diagnosed RA. Incidences of infection were determined from community antibiotic prescriptions and serious infections were determined by hospital discharge coding. Dates of diagnosis and symptom onset allowed identification of asymptomatic/symptomatic pre-RA and early arthritis eras to analyse infection rates over time compared with age- and sex-matched controls. RESULTS: The incidence rate ratio (IRR) seen in the period 0-6 months prior to symptom onset was 1.28 (95% CI 1.15 to 1.42). In 'symptomatic pre-RA', the IRR was 1.33 (95% CI 1.18 to 1.49) which persisted into 'early arthritis'. The rate of hospital admissions was numerically greater in 'pre-RA' and significantly greater in 'early arthritis' (IRR 1.82, 95% CI 1.32 to 2.46). CONCLUSION: Antibiotic risk is increased in patients with 'pre-RA' at least 6 months before symptoms develop, and this persists throughout the symptomatic pre-RA phase. Infections may be important in the mechanisms that drive progression to RA or be a manifestation of immune dysfunction (or both). These observations could inform safety and efficacy considerations for interventions in pre-RA to prevent progression. Patients with 'pre-RA' with recurrent antibiotic use may also be an identifiable 'high risk' group that could enrich the study population for intervention studies in pre-RA.
引用
- Porter D, Jain S, Qian E, et al. Time-varying risks of infection in patients as they proceed through the phases of 'pre-RA': results from the Scottish Early RA inception cohort. RMD Open. 2023. PMID: 37996122. doi:10.1136/rmdopen-2023-003224
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。